The evaluation of the serum brain natriuretic peptide concentrations in preeclamptic and healthy pregnant women and its potential relationship with mean arterial blood pressure

Objective In this study, we aimed to investigate the correlation between serum brain natriuretic peptide (BNP) concentrations and blood pressure levels by comparing serum brain natriuretic peptide (BNP) concentrations in preeclamptic and normotensive pregnant women and to assess its potential role in the preeclampsia pathogenesis. Methods A total of 48 preeclamptic and 39 normotensive patients were included in the study prospectively. Systolic diastolic and mean arterial blood pressure of the pregnant women were measured. Serum BNP concentrations were measured by enzyme immunoassay method. The variable differences between the groups were analyzed by independent samples t-test. Potential correlations between the variables were assessed by Pearson’s correlation analysis. Results There was no difference between the groups in terms of age (26.18±11.49 years vs. 26.04±14.06 years), gestational age (31.59± 6.94 weeks vs. 30.17±5.72 weeks), parity (2.62±1.4 vs. 2.53±1.82) and body mass index (30.71±16.33 kg/m2 vs. 30.09±13.82 kg/m2) (p>0.05). Systolic (148.66± 61.82 mmHg vs. 126.44±97.47 mmHg; p=0.015), diastolic (81.19±52.25 mmHg vs. 97.29±14.27 mmHg; p=0.019) and mean arterial pressure (113.97±41.76 mmHg vs. 96.26±27.25 mmHg; p<0.001) levels were higher in the pregnant women complicated with preeclampsia. In addition, serum BNP concentrations were also higher in the preeclamptic pregnant women than the control group (139.42±62.19 pg/mL vs. 99.28±19.32 pg/mL; p=0.028). BNP levels were significantly associated with only mean arterial pressure (b=0.241, p=0.037). Also, there was a significant positive correlation between BNP levels and mean arterial pressure (r=0.406, p=0.002). Conclusion We recommend further prospective studies with wider populations to assess whether BNP levels, which increase in preeclampsia, are associated with blood pressure levels or not

The effects of different syringe volume, needle size and sample volume on blood gas analysis in syringes washed with heparin

Introductıon: We evaluated the effect of different syringe volume, needle size and sample volume on blood gas analysis in syringes washed with heparin. Materials and methods: In this multi-step experimental study, percent dilution ratios (PDRs) and final heparin concentrations (FHCs) were calculated by gravimetric method for determining the effect of syringe volume (1, 2, 5 and 10 mL), needle size (20, 21, 22, 25 and 26 G) and sample volume (0.5, 1, 2, 5 and 10 mL). The effect of different PDRs and FHCs on blood gas and electrolyte parameters were determined. The erroneous results from nonstandardized sampling were evaluated according to RiliBAK’s TEa. Results: The increase of PDRs and FHCs was associated with the decrease of syringe volume, the increase of needle size and the decrease of sample volume: from 2.0% and 100 IU/mL in 10 mL-syringe to 7.0% and 351 IU/mL in 1 mL-syringe; from 4.9% and 245 IU/mL in 26G to 7.6% and 380 IU/mL in 20 G with combined 1 mL syringe; from 2.0% and 100 IU/mL in full-filled sample to 34% and 1675 IU/mL in 0.5 mL suctioned sample into 10 mL-syringe. There was no statistical difference in pH; but the percent decreasing in pCO2, K+, iCa2+, iMg2+; the percent increasing in pO2 and Na+ were sta-tistical significance compared to samples full-filled in syringes. The all changes in pH and pO2 were acceptable; but the changes in pCO2, Na+, K+ and iCa2+ were unacceptable according to TEa limits except fullfilled-syringes. Conclusions: The changes in PDRs and FHCs due nonstandardized sampling in syringe washed with liquid heparin give rise to erroneous test results for pCO2 and electrolytes